MedPath

Phenytoin in the Healing of Clean Surgical Wounds

Phase 2
Conditions
Wound
Re-Epithelialization
Interventions
Drug: Sugar solution
Registration Number
NCT02413658
Lead Sponsor
Children's Surgical Center, Cambodia
Brief Summary

The purpose of this study is to investigate the potential healing properties of phenytoin.

The investigators will use the donor site of a split skin thickness graft (SSTG) to model a basic wound in a randomized controlled trial of topical phenytoin against current best clinical practice. The investigators aim to demonstrate a dose dependent effect. The investigators hypothesis, based on previous clinical experience at our center and on current available literature, that phenytoin will reduce wound healing time.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Undergoing split thickness skin graft during trial time period at Children's Surgical Centre
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlSugar solutionDressings of best current clinical practice, sugar solution.
Phenytoin 1PhenytoinDressings using phenytoin solution 20mg/ml
Phenytoin 2PhenytoinDressings using phenytoin solution 40mg/ml
Primary Outcome Measures
NameTimeMethod
Percentage rate of re-epithelializationParticipants will be followed for the duration of hospital stay, an expected average of 20 days

Pictures taken of wound site every other day will be analysed using imaging software for size of wound. Percentage rate will be calculated from this.

Appearance of infectionParticipants will be followed for the duration of hospital stay, an expected average of 20 days

Pictures taken of wound site every other day will be analysed using imaging software and the Southampton wound grading scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Children's Surgical Centre

🇰🇭

Phnom Penh, Cambodia

© Copyright 2025. All Rights Reserved by MedPath